These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3502225)

  • 1. [Detection of beta-lactamase-producing bacteria from female patients with acute uncomplicated cystitis].
    Ohkawa M; Yamaguchi K; Orito M; Shimamura M; Hirano S; Hisazumi H
    Hinyokika Kiyo; 1987 Nov; 33(11):1800-5. PubMed ID: 3502225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of beta-lactamase-producing strains isolated from urinary tract and their drug susceptibility].
    Fukatsu H; Yamada H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Yamada Y; Nishikawa E
    Hinyokika Kiyo; 1990 May; 36(5):569-75. PubMed ID: 2399858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: a multicentre study in 2006.
    Kim ME; Ha US; Cho YH
    Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S15-8. PubMed ID: 18096373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta-lactam resistance in aquatic Enterobacter cloacae strains using phenotypic and genotypic criteria].
    Lazăr V; Cernat R; Balotescu C; Cotar A; Coipan E; Cojocaru C
    Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):185-91. PubMed ID: 15085610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections.
    Schito GC; Naber KG; Botto H; Palou J; Mazzei T; Gualco L; Marchese A
    Int J Antimicrob Agents; 2009 Nov; 34(5):407-13. PubMed ID: 19505803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of six beta-lactam antibiotics against non-beta-lactamase producing and producing enterobacteria and antibiotic resistance transfer.
    Scioli C; Esposito S; Martinelli R
    Boll Ist Sieroter Milan; 1984 Sep; 63(4):338-47. PubMed ID: 6335045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Yersinia enterocolitica: the influence of incubation temperature on antibiotic susceptibility, beta-lactamase activity and growth characteristics (author's transl)].
    Kist M; Sanabria de Isele E
    Zentralbl Bakteriol A; 1980 Aug; 247(3):353-63. PubMed ID: 6968487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
    Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-lactamase production by strains of Escherichia coli of intermediate susceptibility to beta-lactam antibiotics. A study of their clinical significance in urinary tract infection.
    Brauner A; Dornbusch K; Hallander HO
    Scand J Infect Dis Suppl; 1978; (13):67-72. PubMed ID: 356181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of beta-lactamase of Staphylococcus intermedius on disk agar diffusion susceptibility tests.
    Roy AF; Newman SS; Cox HU; Hoskins JD
    Cornell Vet; 1984 Oct; 74(4):354-60. PubMed ID: 6332707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
    Xiong Z; Zhu D; Zhang Y; Wang F
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1476-9. PubMed ID: 12509910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams.
    Lerner SA; Quinn JP
    Chemioterapia; 1985 Feb; 4(1):95-101. PubMed ID: 3921267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of beta-lactamase stability and antibacterial activity of beta-lactams in beta-lactamase-producing bacteria and respective transconjugants.
    Esposito S; Galante D; Barba D; Pennucci C; Limauro D
    Drugs Exp Clin Res; 1986; 12(4):329-33. PubMed ID: 3522155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains.
    de Sá Del Fiol F; Rocha De Mattos Filho T; Groppo FC
    Braz J Infect Dis; 2000 Feb; 4(1):36-42. PubMed ID: 10788844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A Polish multicenter survey of antimicrobial susceptibility and prevalence of beta-lactamase production among bacterial pathogens isolated from hospitalized and ambulatory patients].
    Zwolska Z; Jezierska-Anczuków A; Filczak K; Basta M; Dworzyński A; Rogala-Zawada D; Samet A
    Pol Merkur Lekarski; 1998 May; 4(23):241-6. PubMed ID: 9825652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Microorganisms isolated from urinary tract infection and their beta-lactamase production and evaluation of clinical efficacy of sulperazone].
    Kawamura J; Hayashi N; Okabe S; Kawahara S; Chigusa I; Araki T; Saito K; Takeno K; Suzuki N; Suzuki I
    Hinyokika Kiyo; 1988 Aug; 34(8):1503-14. PubMed ID: 3057834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of the urinary tract infections due to Escherichia coli harboring extended-spectrum beta lactamase].
    Hori J; Yamaguchi S; Osanai H; Kinebuchi T; Usami K; Takahashi N; Ishii Y
    Hinyokika Kiyo; 2007 Nov; 53(11):777-82. PubMed ID: 18051801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of bacterial beta-lactamase production in the treatment of urinary tract infections with oral beta-lactam-antibiotics].
    Naber K; Ahrens T; Zimmermann W; Puppel H; Schultheis H; Maly V
    Urologe A; 1982 Jul; 21(4):225-8. PubMed ID: 6982557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-class resistance to non-beta-lactam antimicrobials in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
    Procop GW; Tuohy MJ; Wilson DA; Williams D; Hadziyannis E; Hall GS
    Am J Clin Pathol; 2003 Aug; 120(2):265-7. PubMed ID: 12931557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.